Introduction to Tarceva (Erlotinib) 50mgÂ
Tarceva (Erlotinib) 50mg is a targeted anticancer medicine used in the treatment of certain types of lung cancer and pancreatic cancer. It works by blocking specific growth signals that cancer cells need to grow and multiply.
Tarceva 50mg is classified under Prescription Medicines, Oncology Medicines, Targeted Cancer Therapies, and Tyrosine Kinase Inhibitors (TKIs). It contains Erlotinib, which helps slow or stop the growth of cancer cells.
In some markets, Erutic – 50 50mg is available as a local brand containing the same active ingredient Erlotinib, offering similar therapeutic effects when prescribed by a qualified healthcare professional.
What Is Tarceva (Erlotinib)?Â
Tarceva is the brand name for Erlotinib, an oral medication widely used in targeted cancer therapy.
Erlotinib belongs to a class of medicines known as Epidermal Growth Factor Receptor (EGFR) inhibitors, a type of tyrosine kinase inhibitor. These medicines block signals responsible for cancer cell growth.
Generic versions such as Erutic – 50 50mg contain the same active compound and may be used depending on physician recommendation and availability.
Drug Class and Mechanism of ActionÂ
Erlotinib is classified as an EGFR tyrosine kinase inhibitor with antineoplastic properties.
How Erlotinib WorksÂ
It works in several ways:
- Blocks EGFR signaling pathways
- Inhibits cancer cell proliferation
- Promotes cancer cell death
How Tarceva Works in the BodyÂ
Certain cancers depend on EGFR signals for growth and survival.
Key Actions of ErlotinibÂ
- Slowing tumor growth
- Reducing cancer cell division
- Improving targeted therapy outcomes
Generic versions such as Erutic – 50 provide similar anticancer effects when used correctly.
Medical Uses of Tarceva 50mgÂ
For Non-Small Cell Lung CancerÂ
Erlotinib is commonly used in patients with EGFR mutation-positive non-small cell lung cancer.
Potential BenefitsÂ
- Targeted cancer treatment
- Improved progression-free survival
- Better tolerability compared to some chemotherapy
For Pancreatic CancerÂ
It may be used alongside other treatments in pancreatic cancer.
Treatment BenefitsÂ
- Slowed disease progression
- Improved treatment response
- Enhanced disease control
Who Can Take Erutic – 50 50mg?Â
Eligibility CriteriaÂ
Patients may be prescribed this medicine if they:
- Have lung or pancreatic cancer
- Are suitable for targeted therapy
- Are evaluated by an oncologist
Who Should Avoid Tarceva 50mgÂ
This medicine should NOT be used by:
- Patients with severe liver disease
- Individuals with hypersensitivity to Erlotinib
- Pregnant or breastfeeding women unless advised
Tarceva 50mg Dosage and AdministrationÂ
Standard Dosage GuidelinesÂ
- Typical dose: 50mg once daily (as adjusted by doctor)
- Taken on an empty stomach
- Swallow tablet whole with water
Dosage AdjustmentsÂ
Doctors may adjust dosage depending on:
- Side effects
- Liver function
- Treatment response
Side Effects of Tarceva 50mgÂ
Common Side EffectsÂ
- Skin rash
- Diarrhea
- Fatigue
- Loss of appetite
Serious Side EffectsÂ
- Lung problems (interstitial lung disease)
- Liver toxicity
- Severe skin reactions
- Eye disorders
StorageÂ
Store below 30°C in a dry place, away from moisture and light. Keep out of reach of children.
Frequently Asked Questions (FAQs)Â
1. Is Erlotinib chemotherapy?Â
No, it is a targeted cancer therapy.
2. Should it be taken with food?Â
No, it should be taken on an empty stomach.
3. Can it cause skin problems?Â
Yes, rash is a common side effect.
4. Is it used long-term?Â
Yes, depending on patient response.
5. Is Erutic – 50 the same as Tarceva?Â
Yes, both contain Erlotinib with similar effects.
6. Do I need a prescription?Â
Yes, it is a prescription-only anticancer medicine.
Medical DisclaimerÂ
Disclaimer:
This content is for informational purposes only and should not be considered medical advice. Always consult a qualified healthcare professional before starting cancer treatment.
